Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

25 Mar 2010 16:01

RNS Number : 2130J
Lupus Capital PLC
25 March 2010
 



Lupus Capital plc

(the "Company")

 

Purchase of Ordinary Shares by Directors

 

 

Jamie Pike and Denis Mulhall, Non-Executive Chairman and Chief Operating Officer of the Company respectively, have notified the Company that on 25 March 2010 they purchased ordinary shares of 5p each in the Company ("Shares") as follows:

 

Director

No. of Shares purchased

Price paid per Share

Resultant shareholding

 

Shareholding as % of issued share capital

Jamie Pike

65,000

76.75p

325,000

0.24%

Denis Mulhall

65,000

75.625p

730,000

0.53%

 

 

Enquiries:

 

Collins Stewart Europe Limited

Mark Dickenson / Tom Hulme

+44 (0)20 7523 8350

College Hill

Mark Garraway / Gareth David

+44 (0)20 7457 2020

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSESFMIFSSESD

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.